191 related articles for article (PubMed ID: 8292729)
1. Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease.
Piao YC; Lavergne JM; Boyer-Neumann C; Schandelong A; Alessi MC; Meyer D
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):787-9. PubMed ID: 8292729
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin.
Zhang ZP; Blombäck M; Egberg N; Falk G; Anvret M
Genomics; 1994 May; 21(1):188-93. PubMed ID: 8088787
[TBL] [Abstract][Full Text] [Related]
3. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
[TBL] [Abstract][Full Text] [Related]
4. Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor.
Donnér M; Kristoffersson AC; Berntorp E; Scheibel E; Thorsen S; Dahlbäck B; Nilsson IM; Holmberg L
Eur J Haematol; 1993 Jul; 51(1):38-44. PubMed ID: 8348943
[TBL] [Abstract][Full Text] [Related]
5. Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors.
Mancuso DJ; Tuley EA; Castillo R; de Bosch N; Mannucci PM; Sadler JE
Thromb Haemost; 1994 Aug; 72(2):180-5. PubMed ID: 7831648
[TBL] [Abstract][Full Text] [Related]
6. [Mutation detection enhancement (MDE) gel electrophoresis method for analysis of the von Willebrand factor gene].
Hagiwara T; Inaba H; Fukutake K
Rinsho Byori; 1996 Jun; 44(6):574-8. PubMed ID: 8752737
[TBL] [Abstract][Full Text] [Related]
7. Compound heterozygosity for two novel mutations (1203insG/Y1456X) in the von Willebrand factor gene causing type 3 von Willebrand disease.
Xie F; Wang X; Cooper DN; Lan F; Fang Y; Cai X; Wang Z; Wang H
Haemophilia; 2007 Sep; 13(5):645-8. PubMed ID: 17880457
[TBL] [Abstract][Full Text] [Related]
8. [Detection of gene mutation and genetic analysis of a patient with type 3 von Willebrand disease].
Li Z; Wang Y; Wan H
Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):122-4. PubMed ID: 11243141
[TBL] [Abstract][Full Text] [Related]
9. [Study on genetic mutations of the vWF in type 2A von Willebrand disease].
Wang Y; Zhang J; Zhang W; Cheng D; Wan H; Ruan C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):229-32. PubMed ID: 10932002
[TBL] [Abstract][Full Text] [Related]
10. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.
Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R
Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763
[TBL] [Abstract][Full Text] [Related]
11. Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis.
Kakela JK; Friedman KD; Haberichter SL; Buchholz NP; Christopherson PA; Kroner PA; Gill JC; Montgomery RR; Bellissimo DB
Mol Genet Metab; 2006 Mar; 87(3):262-71. PubMed ID: 16321553
[TBL] [Abstract][Full Text] [Related]
12. L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand disease.
Kashiwagi T; Matsushita T; Ito Y; Hirashima K; Sanda N; Fujimori Y; Yamada T; Okumura K; Takagi A; Murate T; Katsumi A; Takamatsu J; Yamamoto K; Naoe T; Kojima T
Haemophilia; 2008 May; 14(3):556-63. PubMed ID: 18397285
[TBL] [Abstract][Full Text] [Related]
13. Identification of mutations in the canine von Willebrand factor gene associated with type III von Willebrand disease.
Rieger M; Schwarz HP; Turecek PL; Dorner F; van Mourik JA; Mannhalter C
Thromb Haemost; 1998 Aug; 80(2):332-7. PubMed ID: 9716162
[TBL] [Abstract][Full Text] [Related]
14. A standard nomenclature for von Willebrand factor gene mutations and polymorphisms.
Goodeve A; Peake I
Best Pract Res Clin Haematol; 2001 Jun; 14(2):235-40. PubMed ID: 11686097
[TBL] [Abstract][Full Text] [Related]
15. Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM Network on Molecular Abnormalities in von Willebrand Disease.
Meyer D; Fressinaud E; Gaucher C; Lavergne JM; Hilbert L; Ribba AS; Jorieux S; Mazurier C
Thromb Haemost; 1997 Jul; 78(1):451-6. PubMed ID: 9198195
[TBL] [Abstract][Full Text] [Related]
16. Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene.
Hilbert L; Jorieux S; Fontenay-Roupie M; Guicheteau M; Fressinaud E; Meyer D; Mazurier C;
Br J Haematol; 2004 Oct; 127(2):184-9. PubMed ID: 15461624
[TBL] [Abstract][Full Text] [Related]
17. Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
Baronciani L; Federici AB; Cozzi G; La Marca S; Punzo M; Rubini V; Canciani MT; Mannucci PM
Haemophilia; 2008 May; 14(3):549-55. PubMed ID: 18328061
[TBL] [Abstract][Full Text] [Related]
18. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations.
Nesbitt IM; Hampton KK; Preston FE; Peake IR; Goodeve AC
Thromb Haemost; 1999 Sep; 82(3):1061-4. PubMed ID: 10494764
[TBL] [Abstract][Full Text] [Related]
19. Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 families.
Castaman G; Giacomelli S; Rodeghiero F
Acta Haematol; 2009; 121(2-3):106-10. PubMed ID: 19506356
[TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
